id est avocats advised Lymphatica Medtech in their Series A financing round

Lymphatica Medtech, a vascular medical device development start-up, closes their financing round to advance clinical validation aiming at revolutionizing the treatment of chronic lymphedema. The investment round was led by High-Tech Gründerfonds (HTGF), EIT health (European Institute of Innovation and Technology), business angels, and existing investor LIVEventures.

id est avocats advised Lymphatica Medtech in this transaction. The team included Michel Jaccard (Partner, pictured), Marina Castelli, Basile Walder, Léo Schönenberger.

FabioAdmin

SHARE